Kaposi sarcoma incidence in females is nearly four-fold higher in the Lower Rio Grande Valley compared to the Texas average

Hilfinger Messias, 2017, Living in Limbo: Latinas' assessment of Lower Rio Grande Valley Colonias communities, Public Health Nurs., 34, 267, 10.1111/phn.12307 Ryabov, 2011, The role of community health workers in combating type 2 diabetes in the Rio Grande Valley, J. Prim. Care Community Health, 2, 21, 10.1177/2150131910382556 Wehrly, 2010, Confronting the diabetes disparity: a look at diabetes, nutrition, and physical activity programs in the Lower Rio Grande Valley, Health Promot. Pract., 11, 394, 10.1177/1524839908321488 Brown, 2005, Diabetes and the labor market: the community-wide economic cost in the Lower Rio Grande Valley, Diabetes Care., 28, 2945, 10.2337/diacare.28.12.2945 Baillargeon, 2002, High prevalence of human herpesvirus 8 (HHV-8) infection in south Texas children, J. Med. Virol., 67, 542, 10.1002/jmv.10136 Zhang, 2001, Distinct distribution of rare US genotypes of Kaposi's sarcoma-associated herpesvirus (KSHV) in South Texas: implications for KSHV epidemiology, J. Infect. Dis., 183, 125, 10.1086/317650 Zhang, 2000, Distinct distribution of rare us KSHV genotypes in south Texas. Implications for kshv epidemiology and evolution, Ann. Epidemiol., 10, 470, 10.1016/S1047-2797(00)00093-4 Boshoff, 2002, AIDS-related malignancies, Nat. Rev. Cancer, 2, 373, 10.1038/nrc797 1990, AIDS and Kaposi sarcoma pre-1979, Lancet, 335, 969, 10.1016/0140-6736(90)91029-A Presant, 1990, Preliminary report: imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111-labelled liposomes, Lancet, 335, 1307, 10.1016/0140-6736(90)91188-G Ruocco, 2013, Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies, Clin. Dermatol., 31, 413, 10.1016/j.clindermatol.2013.01.008 Hayat, 2007, Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program, Oncologist, 12, 20, 10.1634/theoncologist.12-1-20 Volkow, 2016, Historical Review of Kaposi sarcoma in pre-HAART era: evolution with different chemotherapy schedules and remission with ganciclovir use, Gac. Med. Mex., 152, 96 Nelwan, 2014, Kaposi sarcoma of the eye in an HIV patient well-responded to HAART, Acta Med. Indones., 46, 253 La Ferla, 2013, Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era, Eur. Rev. Med. Pharmacol. Sci., 17, 2354 Campo-Trapero, 2008, Relationship between oral Kaposi 's sarcoma and HAART: contribution of two case reports, Med. Oral Patol. Oral Cir. Bucal., 13, E709 Paparizos, 2008, The Influence of a HAART regimen on the expression of HIV-associated Kaposi sarcoma, J. Acquir. Immune Defic. Syndr., 49, 111, 10.1097/QAI.0b013e31816d9d2b Fan, 2015, Moritz Kaposi, Jama Dermatol, 151, 622, 10.1001/jamadermatol.2015.106 Mitre, 2017, Classic Kaposi sarcoma in an HIV-negative Han Chinese man: a case report, Dermatol. Online J., 23, 10.5070/D3231033679 Jakob, 2011, Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome, PLoS One, 6, e18397, 10.1371/journal.pone.0018397 Csire, 2007, Persistent long-term human herpesvirus 6 (HHV-6) infection in a patient with langerhans cell histiocytosis, Pathol. Oncol. Res., 13, 157, 10.1007/BF02893493 Gaidano, 1996, Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions, Leukemia, 10, 1237 Moore, 1996, Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae, J. Virol., 70, 549, 10.1128/JVI.70.1.549-558.1996 Chang, 1996, Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS, Infect. Agents Dis., 5, 215 Foreman, 2001, Injection of human herpesvirus-8 in human skin engrafted on SCID mice induces Kaposi's sarcoma-like lesions, J. Dermatol. Sci., 26, 182, 10.1016/S0923-1811(01)00087-1 Simonart, 2006, Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi sarcoma, Cancer Lett., 244, 1, 10.1016/j.canlet.2006.02.005 Sissolak, 2005, AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa, Trop. Med. Int. Health, 10, 981, 10.1111/j.1365-3156.2005.01491.x Vellanki, 2017, Diabetic ketoacidosis: a common debut of diabetes among African Americans with Type 2 diabetes, Endocr. Pract., 23, 971, 10.4158/EP161679.RA Piras, 2017, High prevalence of human herpesvirus 8 infection in diabetes type 2 patients and detection of a new virus subtype, Adv. Exp. Med. Biol., 973, 41, 10.1007/5584_2016_73 Cikomola, 2016, The association between fructosamine-3 kinase 900C/G polymorphism, transferrin polymorphism and human herpesvirus-8 infection in diabetics living in South Kivu, Acta Trop., 163, 14, 10.1016/j.actatropica.2016.07.011 Nguewa, 2017, Relationship between HHV8 infection markers and insulin sensitivity in ketosis-prone diabetes, Diabetes Metab., 43, 79, 10.1016/j.diabet.2016.05.004 Liu, 2016, Idiopathic multicentric Castleman's disease: a systematic literature review, Lancet Haematol., 3, e163, 10.1016/S2352-3026(16)00006-5 Rubicz, 2015, Genome-wide genetic investigation of serological measures of common infections, Eur. J. Hum. Genet., 23, 1544, 10.1038/ejhg.2015.24 Caselli, 2014, High prevalence of HHV8 infection and specific killer cell immunoglobulin-like receptors allotypes in Sardinian patients with type 2 diabetes mellitus, J. Med. Virol., 86, 1745, 10.1002/jmv.23771 Su, 2013, High seroprevalence of human herpesvirus type 8 in patients with end-stage renal disease in Taiwan, J. Clin. Virol., 58, 89, 10.1016/j.jcv.2013.06.005 Goedert, 2009, Nonsmoking and other cofactors for Kaposi's sarcoma, AIDS, 23, 273, 10.1097/QAD.0b013e32831f4674 Sobngwi, 2008, Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-Saharan Africans, JAMA, 299, 2770, 10.1001/jama.299.23.2770 Guttman-Yassky, 2006, Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk?, Cancer, 106, 413, 10.1002/cncr.21614 Crispo, 2001, HHV-8 prevalence, immunosuppression and Kaposi's sarcoma in South Italy, Int. J. Mol. Med., 7, 535 Krown, 1989, Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee, J. Clin. Oncol., 7, 1201, 10.1200/JCO.1989.7.9.1201 Peterson, 1987, Texas statewide cancer registry, Tex. Med., 83, 5 Registry Rosner, 2011, Fundamentals of Biostatistics, xvii, 859 Fay, 1997, Confidence intervals for directly standardized rates: a method based on the gamma distribution, Stat. Med., 16, 791, 10.1002/(SICI)1097-0258(19970415)16:7<791::AID-SIM500>3.0.CO;2-# Anderson, 1998, Age standardization of death rates: implementation of the year 2000 standard, Natl. Vital Stat. Rep., 47, 1 Gilliland, 1997, Risk factor information found in medical records of lung and prostate cancer cases, New Mexico tumor registry (United States), Cancer Causes Control., 8, 598, 10.1023/A:1018494313389 Registry, 2015, Identifying barriers and developing strategies to improve melanoma reporting by physicians in Arizona, J. Registry Manag., 42, 25 Bragg, 1957, The California tumor registry: a summary report on the cancer experience in 36 hospitals, Calif. Med., 87, 180 Kimmel, 2016, Racial disparities in poverty account for mortality differences in US medicare beneficiaries, SSM Popul. Health, 2, 123, 10.1016/j.ssmph.2016.02.003 Kreider, 2016, Quality of health insurance coverage and access to care for children in low-income families, JAMA Pediatr., 170, 43, 10.1001/jamapediatrics.2015.3028 Millard, 2017, Diabetes screening and prevention in a high-risk, medically isolated border community, Front Public Health, 5, 135, 10.3389/fpubh.2017.00135 Lee, 2014, Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins, Biochem. Biophys. Res. Commun., 445, 120, 10.1016/j.bbrc.2014.01.130 Chan, 2013, The utility of immunohistochemistry for providing genetic information on tumors, Int. J. Surg. Pathol., 21, 455, 10.1177/1066896913502529 Subramaniam, 2013, Dedifferentiated liposarcoma with unusual kaposiform morphology and whorl formation masquerading As Kaposi's sarcoma: diagnostically challenging case confirmed by cytogenetic and TP53 mutation analysis, J. Clin. Oncol., 31, e101, 10.1200/JCO.2012.42.8763 Ye, 2012, Nutlin-3 induces apoptosis, disrupts viral latency and inhibits expression of angiopoietin-2 in Kaposi sarcoma tumor cells, Cell Cycle, 11, 1393, 10.4161/cc.19756 Sadagopan, 2012, Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival, Oncogene, 31, 4835, 10.1038/onc.2011.648 Tornesello, 2011, MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients, Biomarkers, 16, 42, 10.3109/1354750X.2010.525664 Sarek, 2007, p53 reactivation kills KSHV lymphomas efficiently in vitro and in vivo: new hope for treating aggressive viral lymphomas, Cell Cycle, 6, 2205, 10.4161/cc.6.18.4730 Sarek, 2007, Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas, J. Clin. Invest., 117, 1019, 10.1172/JCI30945 Sun, 2001, Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus, Biochem. Biophys. Res. Commun., 287, 983, 10.1006/bbrc.2001.5689 Li, 1997, Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi's sarcoma, Am. J. Dermatopathol., 19, 373, 10.1097/00000372-199708000-00009 Haupt, 1997, Mdm2 promotes the rapid degradation of p53, Nature, 387, 296, 10.1038/387296a0 Robbins, 2015, Excess cancers among HIV-infected people in the United States, J. Natl. Cancer Inst., 107, 10.1093/jnci/dju503